| Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities (NCT05349383) | Central South University | 2022-04-22 |
| T Cell Therapy of Opportunistic Cytomegalovirus Infection (NCT02982902) | Mari Dallas | 2020-05-27 |
| Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells (NCT03798301) | University of Wisconsin, Madison | 2020-02-06 |
| Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria (NCT03087890) | University of Bergen | 2017-03-30 |
| CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT (NCT02942173) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2016-10-01 |
| Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation (NCT02337595) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2014-08-01 |
| Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients (NCT03083756) | Sociedad Española de Trasplante | 2014-08-01 |
| A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes (NCT01541631) | Catholic University of Health and Allied Sciences | 2012-05-01 |
| Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome (NCT01557803) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-01-01 |
| Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma (NCT00814827) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-07 |
| Vicente Ferrer HIV Cohort Study (NCT02454569) | Rural Development Trust Hospital | 2009-09-01 |
| Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance (NCT00137657) | Centers for Disease Control and Prevention | 2002-02-01 |
| Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy (NCT00001477) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-08-01 |